1. 1) Uehara S, Fujio K, Yamasaki T, Otsuki H. The significance of age and causative bacterial morphology in the choice of an antimicrobial agent to treat acute uncomplicated cystitis. Acta Med. Okayama, 75, 719–724 (2021).
2. 2) Fujimura T, Yoshida I, Yamano Y. Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents. Jpn. J. Antibiot., 60, 17–30 (2007).
3. 3) Ishihara R, Ishii Y, Suzuki Y, Nakazawa A, Deguchi K, Toyonaga Y. Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients. Jpn. J. Antibiot., 51, 1–10 (1998).
4. 4) Oshiro T, Fukutomi Y, Takayanagi M, Kusaba K, Nagasawa Z, Aoki Y, Nagayama A. Antibacterial activity of oral Cephems against various clinically isolated strains. Jpn. J. Antibiot., 56, 681–690 (2003).
5. 5) Alba J, Ishii Y, Galleni M, Frère JM, Ito M, Yamaguchi K. Cefcapene inactivates chromosome-encoded class C beta-lactamases. J. Infect. Chemother., 8, 207–210 (2002).